Dr. Reddy’s sets September 2026 investor meetings

Dr. Reddy’s Laboratories schedules September 2026 group meetings with institutional investors in Hyderabad and via virtual conference.

Rhea-AI Filing Summary

DR REDDYS LABORATORIES LTD (RDY) reports as a foreign private issuer on Form 6-K that its management plans to participate in upcoming analyst and institutional investor meetings. The company will attend investor conferences organized by ICICI Securities on September 17, 2026 in Hyderabad and by Bank of America on September 24, 2026 via a virtual format.

Both meetings are scheduled as group meetings, with the ICICI Securities session from 12:30 to 13:30 IST and the Bank of America session from 14:00 to 15:00 IST. The company notes that this schedule may change due to exigencies on the part of investors or the company.

Key Figures

Meeting date 1: September 17, 2026 Meeting time 1: 12:30–13:30 IST Meeting date 2: September 24, 2026 +1 more

4 metrics

Meeting date 1 September 17, 2026 ICICI Securities group investor meet in Hyderabad

Meeting time 1 12:30–13:30 IST ICICI Securities in-person group meet

Meeting date 2 September 24, 2026 Bank of America virtual group investor meet

Meeting time 2 14:00–15:00 IST Bank of America virtual group meet

Key Terms

Form 6-K, foreign private issuer, Regulation 30, SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, +1 more

5 terms

Form 6-K regulatory

"Form 6-K REPORT OF FOREIGN PRIVATE ISSUER"

A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.

foreign private issuer regulatory

"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

Regulation 30 regulatory

"Intimation under Regulation 30 of the SEBI"

SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regulatory

"under Regulation 30 of the SEBI (Listing Obligations"

Institutional Investor Meetings financial

"Schedule of Analyst / Institutional Investor Meetings"

FAQ

What does Dr. Reddy’s Laboratories (RDY) announce in this Form 6-K?

Dr. Reddy’s Laboratories announces that its management will participate in analyst and institutional investor conferences, providing a schedule of group meetings in September 2026 with ICICI Securities and Bank of America under Regulation 30 of the SEBI LODR Regulations.

When are the scheduled investor meetings for RDY in September 2026?

The company plans two group investor meetings: on September 17, 2026 with ICICI Securities from 12:30–13:30 IST in Hyderabad, and on September 24, 2026 with Bank of America from 14:00–15:00 IST via a virtual meeting mode.

Who is organizing the upcoming Dr. Reddy’s (RDY) investor conferences?

The meetings are organized by ICICI Securities, hosting an in-person group meet in Hyderabad on September 17, 2026, and by Bank of America, hosting a virtual group meet on September 24, 2026, both involving analyst and institutional investor interactions.

What is the nature and mode of the RDY analyst and investor meetings?

Both sessions are described as Group Meet. The September 17, 2026 meeting with ICICI Securities will be held in-person in Hyderabad, while the September 24, 2026 meeting with Bank of America will be conducted in a virtual meeting mode.

Can the schedule of Dr. Reddy’s (RDY) investor meetings change?

Yes. Dr. Reddy’s states that the schedule is subject to change due to any exigencies on the part of investors or the company, indicating that timing or participation details may be adjusted if necessary.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 11:21 AM Accepted by SEC EDGAR 09/10/2026 - 11:21 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

September, 2026

Commission File Number 1-15182

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x                         Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ______

Note:  Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ______

Note:  Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨                         No x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

EXHIBITS

Exhibit Number		Description of Exhibits
99.1		Intimation dated September 10, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DR. REDDY’S LABORATORIES LIMITED (Registrant)
Date: September 10, 2026	By:	/s/ K Randhir Singh
		Name:	K Randhir Singh
		Title:	Company Secretary

Exhibit 99.1

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India CIN: L85195TG1984PLC004507 Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.com

September 10, 2026

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)

BSE Limited (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/Madam,

Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings

This is to inform that the Company’s management will be participating in the following investor conference with single institution(s)/ investor groups:

Date	Organized by	Location	Meeting mode	Nature of meet	Timing
17.09.2026	ICICI Securities	Hyderabad	In-Person	Group Meet	12:30 - 13:30 IST
24.09.2026	Bank of America	-	Virtual	Group Meet	14:00 - 15:00 IST

Please note that the schedule of the aforesaid meeting is subject to change due to any exigencies on the part of Investors / Company.

This is for your information.

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

K Randhir Singh

Company Secretary, Compliance Officer & Head-CSR

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EXHIBIT 99.1 41.2 KB